Drug Trial Radar · NCT03026907
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
Last checked: Nov 20, 2026Latest source record: May 4, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
116
Planned (sponsor's estimate)
Start
May 2016
Primary completion
Dec 2019
Study completion Dec 2019
Sponsor
- Lead sponsor
- University Medical Center GroningenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 20, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of alitretinoin and azathioprine in the treatment of patients with severe chronic non-hyperkeratotic hand eczema.
Conditions
- Hand Eczema
Interventions
AlitretinoinDrug
Oral alitretinoin capsule of 30mg once daily for a total of 24 weeks.
AzathioprineDrug
Oral azathioprine tablets twice daily in a dose of 1.5 or 2.5mg/kg/day, depending on the thiopurine methyltransferase (TPMT) activity.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response to treatment/hand eczema severity (Photoguide)Time frame: 24 weeks (end of treatment)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Medical Center Groningen
Groningen, Netherlands · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.